Outcomes after bronchoscopic lung volume reduction (BLVR) for patients with advanced emphysema were not significantly affected by the level of heterogeneity before the procedure, based on data from ...
Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for high-grade serous ovarian carcinoma (HGSOC). Patient selection for ADC therapy depends on tumour target expression, ...
Prostate-specific membrane antigen (PSMA)-targeted theranostics have profoundly reshaped prostate cancer (PCa) management. However, patterns of PSMA expression heterogeneity and the identification of ...